Preload Image
Preload Image
Report Store mobile icon
Global Neuro Stimulation Devices Market Growth 2024-2030

Global Neuro Stimulation Devices Market Growth 2024-2030

2024

Global Neuro Stimulation Devices Market Growth 2024-2030

The global neuro stimulation devices market is valued at US$ 13.31 billion in 2024, with rising demand for non-invasive treatments for neurological conditions.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global neurostimulation devices market is expanding rapidly, driven by the increasing prevalence of neurological disorders and advancements in medical technology. Neurostimulation devices are used to treat various conditions, including chronic pain, Parkinson’s disease, epilepsy, depression, and other neurological conditions, by delivering electrical impulses to specific areas of the nervous system. The growing demand for non-invasive treatment options and the rising awareness of neurological disorders have contributed to the growth of this market. Additionally, the increasing geriatric population, who are more prone to neurological disorders, is another factor fueling market growth. As patients seek alternative treatment options to traditional medications, neurostimulation therapies are becoming increasingly popular due to their effectiveness in improving patients' quality of life and reducing the side effects associated with pharmaceutical treatments. These devices are generally classified into categories such as spinal cord stimulators, deep brain stimulators, transcranial magnetic stimulators, and others, each designed to address specific conditions and provide targeted therapeutic benefits. The continuous innovation in device technology, such as the development of wireless, rechargeable, and minimally invasive neurostimulation devices, is further enhancing their appeal in the market. The increasing demand for these devices is also being supported by regulatory bodies like the FDA, which have approved several neurostimulation therapies for the treatment of conditions like chronic pain, depression, and epilepsy. With ongoing advancements in medical research and technology, the neurostimulation devices market is expected to experience sustained growth in the coming years, offering new hope to patients with neurological conditions.

According to Publisher, global Neuro Stimulation Devices market size was valued at US$ 13310 million in 2024. With growing demand in downstream market, the Neuro Stimulation Devices is forecast to a readjusted size of US$ 16620 million by 2030 with a CAGR of 3.2% during review period. North America holds a significant share of the global neurostimulation devices market, driven by the presence of advanced healthcare infrastructure, high healthcare expenditure, and increasing adoption of innovative medical technologies. The United States, in particular, is a major contributor to the market, with a high demand for neurostimulation devices due to the growing prevalence of neurological disorders such as chronic pain, epilepsy, and depression. The well-established reimbursement policies in North America also contribute to the growth of the market, making these devices more accessible to patients. Furthermore, the region’s strong research and development capabilities, coupled with the presence of key players in the neurostimulation devices market, ensure continued innovation and product development. Europe follows closely behind North America in terms of market share, with countries like Germany, France, and the United Kingdom being significant contributors. The European market is growing due to the increasing awareness of neurostimulation therapies and the rising prevalence of neurological diseases, particularly in the aging population. In addition, favorable regulatory frameworks and government initiatives aimed at improving healthcare access are boosting the market growth in Europe. The Asia-Pacific region is expected to witness the highest growth in the neurostimulation devices market, primarily due to the rising prevalence of neurological disorders and the growing healthcare infrastructure in countries such as China and India. The increasing adoption of advanced medical technologies and rising disposable incomes are contributing to the market’s expansion in the region. The growing focus on improving healthcare standards in emerging economies and the demand for cost-effective treatments further supports the growth of the neurostimulation devices market in Asia-Pacific. Additionally, the Middle East and Latin America are also witnessing an increase in the adoption of neurostimulation devices, driven by improvements in healthcare systems and growing awareness of neurological disorders.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The global neurostimulation devices market is segmented by type, with key categories including spinal cord stimulators, deep brain stimulators, transcranial magnetic stimulators, sacral nerve stimulators, and others. Spinal cord stimulators are one of the most commonly used neurostimulation devices, primarily used to treat chronic pain, particularly in patients with conditions like failed back surgery syndrome and complex regional pain syndrome. These devices are implanted in the epidural space and deliver electrical impulses to the spinal cord, modifying pain signals before they reach the brain. Deep brain stimulators, on the other hand, are used to treat neurological conditions like Parkinson’s disease, essential tremor, and dystonia by delivering electrical pulses to specific brain areas. These devices are increasingly being used as an alternative to medication, especially for patients who do not respond well to drug therapy. Transcranial magnetic stimulators are non-invasive devices that use magnetic fields to stimulate specific brain areas and are primarily used for the treatment of depression, particularly in patients who do not respond to traditional antidepressant medications. Sacral nerve stimulators are used to treat bladder and bowel dysfunction, including conditions like urinary incontinence and fecal incontinence, by stimulating the sacral nerves that control the bladder and bowel muscles. Other types of neurostimulation devices include those used for the treatment of conditions like obesity, tinnitus, and epilepsy, further diversifying the market. As technology continues to advance, the development of new neurostimulation devices with improved features, such as better control over stimulation parameters and more patient-friendly designs, is expected to drive growth in these segments. The increasing adoption of these devices in clinical settings, coupled with their proven efficacy in treating a wide range of neurological conditions, will continue to fuel the demand for neurostimulation devices globally.

The neurostimulation devices market is also segmented by application, with key categories including chronic pain management, movement disorders, depression, epilepsy, and others. Chronic pain management is one of the largest applications of neurostimulation devices, as these devices have been shown to be highly effective in alleviating pain for patients with conditions like neuropathic pain, back pain, and joint pain. Spinal cord stimulators are particularly popular in this segment, as they can significantly reduce the intensity of pain and improve patients' quality of life. Movement disorders, such as Parkinson’s disease and essential tremor, also represent a significant application area for neurostimulation devices, with deep brain stimulators being the most widely used device in this category. These devices have been shown to improve motor function and reduce symptoms like tremors, rigidity, and bradykinesia in patients with movement disorders. The increasing prevalence of conditions like Parkinson’s disease, particularly among the aging population, is driving the demand for neurostimulation devices in this segment. Depression is another key application area, with transcranial magnetic stimulators offering a non-invasive treatment option for patients with major depressive disorder, particularly those who do not respond to medication. The growing awareness of mental health disorders and the shift toward more personalized treatment options are expected to boost the demand for neurostimulation devices in this area. Epilepsy is also a significant application of neurostimulation devices, with devices like responsive neurostimulation systems being used to treat drug-resistant epilepsy by delivering electrical impulses to the brain to prevent seizures. As more patients seek alternative treatments for epilepsy, the demand for neurostimulation devices is expected to increase. Other applications of neurostimulation devices include the treatment of conditions like tinnitus, incontinence, and obesity, further expanding the market’s reach. As new indications for neurostimulation therapies are explored, the market for these devices is expected to diversify and grow, providing effective solutions for a wide range of neurological conditions.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Neuro Stimulation Devices Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Neuro Stimulation Devices by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Neuro Stimulation Devices by Country/Region, 2019, 2023 & 2030
  • 2.2 Neuro Stimulation Devices Segment by Type
  • 2.2.1 DBS(Deep-Brain Stimulation)
  • 2.2.2 VNS(Vagus Nerve Stimulation)
  • 2.2.3 RNS(Responsive Neuro Stimulation)
  • 2.2.4 TMS(Transcranial Magnetic Stimulation)
  • 2.2.5 SCS(Spinal Cord Stimulation)
  • 2.2.6 PNS(Peripheral Nerve Stimulation)
  • 2.3 Neuro Stimulation Devices Sales by Type
  • 2.3.1 Global Neuro Stimulation Devices Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Neuro Stimulation Devices Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Neuro Stimulation Devices Sale Price by Type (2019-2024)
  • 2.4 Neuro Stimulation Devices Segment by Application
  • 2.4.1 Pain Management
  • 2.4.2 Parkinson’S Disease
  • 2.4.3 Urinary and Fecal Incontinence
  • 2.4.4 Epilepsy
  • 2.4.5 Hearing Loss
  • 2.4.6 Gastroparesis
  • 2.4.7 Depression
  • 2.4.8 Others
  • 2.5 Neuro Stimulation Devices Sales by Application
  • 2.5.1 Global Neuro Stimulation Devices Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Neuro Stimulation Devices Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Neuro Stimulation Devices Sale Price by Application (2019-2024)
  • 3 Global Neuro Stimulation Devices by Company
  • 3.1 Global Neuro Stimulation Devices Breakdown Data by Company
  • 3.1.1 Global Neuro Stimulation Devices Annual Sales by Company (2019-2024)
  • 3.1.2 Global Neuro Stimulation Devices Sales Market Share by Company (2019-2024)
  • 3.2 Global Neuro Stimulation Devices Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Neuro Stimulation Devices Revenue by Company (2019-2024)
  • 3.2.2 Global Neuro Stimulation Devices Revenue Market Share by Company (2019-2024)
  • 3.3 Global Neuro Stimulation Devices Sale Price by Company
  • 3.4 Key Manufacturers Neuro Stimulation Devices Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Neuro Stimulation Devices Product Location Distribution
  • 3.4.2 Players Neuro Stimulation Devices Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Neuro Stimulation Devices by Geographic Region
  • 4.1 World Historic Neuro Stimulation Devices Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Neuro Stimulation Devices Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Neuro Stimulation Devices Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Neuro Stimulation Devices Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Neuro Stimulation Devices Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Neuro Stimulation Devices Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Neuro Stimulation Devices Sales Growth
  • 4.4 APAC Neuro Stimulation Devices Sales Growth
  • 4.5 Europe Neuro Stimulation Devices Sales Growth
  • 4.6 Middle East & Africa Neuro Stimulation Devices Sales Growth
  • 5 Americas
  • 5.1 Americas Neuro Stimulation Devices Sales by Country
  • 5.1.1 Americas Neuro Stimulation Devices Sales by Country (2019-2024)
  • 5.1.2 Americas Neuro Stimulation Devices Revenue by Country (2019-2024)
  • 5.2 Americas Neuro Stimulation Devices Sales by Type
  • 5.3 Americas Neuro Stimulation Devices Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Neuro Stimulation Devices Sales by Region
  • 6.1.1 APAC Neuro Stimulation Devices Sales by Region (2019-2024)
  • 6.1.2 APAC Neuro Stimulation Devices Revenue by Region (2019-2024)
  • 6.2 APAC Neuro Stimulation Devices Sales by Type
  • 6.3 APAC Neuro Stimulation Devices Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Neuro Stimulation Devices by Country
  • 7.1.1 Europe Neuro Stimulation Devices Sales by Country (2019-2024)
  • 7.1.2 Europe Neuro Stimulation Devices Revenue by Country (2019-2024)
  • 7.2 Europe Neuro Stimulation Devices Sales by Type
  • 7.3 Europe Neuro Stimulation Devices Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Neuro Stimulation Devices by Country
  • 8.1.1 Middle East & Africa Neuro Stimulation Devices Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Neuro Stimulation Devices Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Neuro Stimulation Devices Sales by Type
  • 8.3 Middle East & Africa Neuro Stimulation Devices Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Neuro Stimulation Devices
  • 10.3 Manufacturing Process Analysis of Neuro Stimulation Devices
  • 10.4 Industry Chain Structure of Neuro Stimulation Devices
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Neuro Stimulation Devices Distributors
  • 11.3 Neuro Stimulation Devices Customer
  • 12 World Forecast Review for Neuro Stimulation Devices by Geographic Region
  • 12.1 Global Neuro Stimulation Devices Market Size Forecast by Region
  • 12.1.1 Global Neuro Stimulation Devices Forecast by Region (2025-2030)
  • 12.1.2 Global Neuro Stimulation Devices Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Neuro Stimulation Devices Forecast by Type
  • 12.7 Global Neuro Stimulation Devices Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Medtronic(U.S)
  • 13.1.1 Medtronic(U.S) Company Information
  • 13.1.2 Medtronic(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.1.3 Medtronic(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Medtronic(U.S) Main Business Overview
  • 13.1.5 Medtronic(U.S) Latest Developments
  • 13.2 St. Jude Medical(U.S)
  • 13.2.1 St. Jude Medical(U.S) Company Information
  • 13.2.2 St. Jude Medical(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.2.3 St. Jude Medical(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 St. Jude Medical(U.S) Main Business Overview
  • 13.2.5 St. Jude Medical(U.S) Latest Developments
  • 13.3 Boston Scientific(U.S)
  • 13.3.1 Boston Scientific(U.S) Company Information
  • 13.3.2 Boston Scientific(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.3.3 Boston Scientific(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Boston Scientific(U.S) Main Business Overview
  • 13.3.5 Boston Scientific(U.S) Latest Developments
  • 13.4 Cyberonics(U.S)
  • 13.4.1 Cyberonics(U.S) Company Information
  • 13.4.2 Cyberonics(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.4.3 Cyberonics(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Cyberonics(U.S) Main Business Overview
  • 13.4.5 Cyberonics(U.S) Latest Developments
  • 13.5 Cochlear(Australia)
  • 13.5.1 Cochlear(Australia) Company Information
  • 13.5.2 Cochlear(Australia) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.5.3 Cochlear(Australia) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Cochlear(Australia) Main Business Overview
  • 13.5.5 Cochlear(Australia) Latest Developments
  • 13.6 NDI Medical(U.S)
  • 13.6.1 NDI Medical(U.S) Company Information
  • 13.6.2 NDI Medical(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.6.3 NDI Medical(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 NDI Medical(U.S) Main Business Overview
  • 13.6.5 NDI Medical(U.S) Latest Developments
  • 13.7 NeuroPace(U.S)
  • 13.7.1 NeuroPace(U.S) Company Information
  • 13.7.2 NeuroPace(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.7.3 NeuroPace(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 NeuroPace(U.S) Main Business Overview
  • 13.7.5 NeuroPace(U.S) Latest Developments
  • 13.8 ElectroCore Medical(U.S)
  • 13.8.1 ElectroCore Medical(U.S) Company Information
  • 13.8.2 ElectroCore Medical(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.8.3 ElectroCore Medical(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 ElectroCore Medical(U.S) Main Business Overview
  • 13.8.5 ElectroCore Medical(U.S) Latest Developments
  • 13.9 MED-EL(U.S)
  • 13.9.1 MED-EL(U.S) Company Information
  • 13.9.2 MED-EL(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.9.3 MED-EL(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 MED-EL(U.S) Main Business Overview
  • 13.9.5 MED-EL(U.S) Latest Developments
  • 13.10 Neuronetics(U.S)
  • 13.10.1 Neuronetics(U.S) Company Information
  • 13.10.2 Neuronetics(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
  • 13.10.3 Neuronetics(U.S) Neuro Stimulation Devices Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 Neuronetics(U.S) Main Business Overview
  • 13.10.5 Neuronetics(U.S) Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Neuro Stimulation Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neuro Stimulation Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of DBS(Deep-Brain Stimulation)
Table 4. Major Players of VNS(Vagus Nerve Stimulation)
Table 5. Major Players of RNS(Responsive Neuro Stimulation)
Table 6. Major Players of TMS(Transcranial Magnetic Stimulation)
Table 7. Major Players of SCS(Spinal Cord Stimulation)
Table 8. Major Players of PNS(Peripheral Nerve Stimulation)
Table 9. Global Neuro Stimulation Devices Sales by Type (2019-2024) & (Units)
Table 10. Global Neuro Stimulation Devices Sales Market Share by Type (2019-2024)
Table 11. Global Neuro Stimulation Devices Revenue by Type (2019-2024) & ($ million)
Table 12. Global Neuro Stimulation Devices Revenue Market Share by Type (2019-2024)
Table 13. Global Neuro Stimulation Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 14. Global Neuro Stimulation Devices Sales by Application (2019-2024) & (Units)
Table 15. Global Neuro Stimulation Devices Sales Market Share by Application (2019-2024)
Table 16. Global Neuro Stimulation Devices Revenue by Application (2019-2024)
Table 17. Global Neuro Stimulation Devices Revenue Market Share by Application (2019-2024)
Table 18. Global Neuro Stimulation Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 19. Global Neuro Stimulation Devices Sales by Company (2019-2024) & (Units)
Table 20. Global Neuro Stimulation Devices Sales Market Share by Company (2019-2024)
Table 21. Global Neuro Stimulation Devices Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Neuro Stimulation Devices Revenue Market Share by Company (2019-2024)
Table 23. Global Neuro Stimulation Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 24. Key Manufacturers Neuro Stimulation Devices Producing Area Distribution and Sales Area
Table 25. Players Neuro Stimulation Devices Products Offered
Table 26. Neuro Stimulation Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Neuro Stimulation Devices Sales by Geographic Region (2019-2024) & (Units)
Table 30. Global Neuro Stimulation Devices Sales Market Share Geographic Region (2019-2024)
Table 31. Global Neuro Stimulation Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Neuro Stimulation Devices Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Neuro Stimulation Devices Sales by Country/Region (2019-2024) & (Units)
Table 34. Global Neuro Stimulation Devices Sales Market Share by Country/Region (2019-2024)
Table 35. Global Neuro Stimulation Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Neuro Stimulation Devices Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Neuro Stimulation Devices Sales by Country (2019-2024) & (Units)
Table 38. Americas Neuro Stimulation Devices Sales Market Share by Country (2019-2024)
Table 39. Americas Neuro Stimulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Neuro Stimulation Devices Revenue Market Share by Country (2019-2024)
Table 41. Americas Neuro Stimulation Devices Sales by Type (2019-2024) & (Units)
Table 42. Americas Neuro Stimulation Devices Sales by Application (2019-2024) & (Units)
Table 43. APAC Neuro Stimulation Devices Sales by Region (2019-2024) & (Units)
Table 44. APAC Neuro Stimulation Devices Sales Market Share by Region (2019-2024)
Table 45. APAC Neuro Stimulation Devices Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Neuro Stimulation Devices Revenue Market Share by Region (2019-2024)
Table 47. APAC Neuro Stimulation Devices Sales by Type (2019-2024) & (Units)
Table 48. APAC Neuro Stimulation Devices Sales by Application (2019-2024) & (Units)
Table 49. Europe Neuro Stimulation Devices Sales by Country (2019-2024) & (Units)
Table 50. Europe Neuro Stimulation Devices Sales Market Share by Country (2019-2024)
Table 51. Europe Neuro Stimulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Neuro Stimulation Devices Revenue Market Share by Country (2019-2024)
Table 53. Europe Neuro Stimulation Devices Sales by Type (2019-2024) & (Units)
Table 54. Europe Neuro Stimulation Devices Sales by Application (2019-2024) & (Units)
Table 55. Middle East & Africa Neuro Stimulation Devices Sales by Country (2019-2024) & (Units)
Table 56. Middle East & Africa Neuro Stimulation Devices Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Neuro Stimulation Devices Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Neuro Stimulation Devices Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Neuro Stimulation Devices Sales by Type (2019-2024) & (Units)
Table 60. Middle East & Africa Neuro Stimulation Devices Sales by Application (2019-2024) & (Units)
Table 61. Key Market Drivers & Growth Opportunities of Neuro Stimulation Devices
Table 62. Key Market Challenges & Risks of Neuro Stimulation Devices
Table 63. Key Industry Trends of Neuro Stimulation Devices
Table 64. Neuro Stimulation Devices Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Neuro Stimulation Devices Distributors List
Table 67. Neuro Stimulation Devices Customer List
Table 68. Global Neuro Stimulation Devices Sales Forecast by Region (2025-2030) & (Units)
Table 69. Global Neuro Stimulation Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Neuro Stimulation Devices Sales Forecast by Country (2025-2030) & (Units)
Table 71. Americas Neuro Stimulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Neuro Stimulation Devices Sales Forecast by Region (2025-2030) & (Units)
Table 73. APAC Neuro Stimulation Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Neuro Stimulation Devices Sales Forecast by Country (2025-2030) & (Units)
Table 75. Europe Neuro Stimulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Neuro Stimulation Devices Sales Forecast by Country (2025-2030) & (Units)
Table 77. Middle East & Africa Neuro Stimulation Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Neuro Stimulation Devices Sales Forecast by Type (2025-2030) & (Units)
Table 79. Global Neuro Stimulation Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Neuro Stimulation Devices Sales Forecast by Application (2025-2030) & (Units)
Table 81. Global Neuro Stimulation Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Medtronic(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Medtronic(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 84. Medtronic(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Medtronic(U.S) Main Business
Table 86. Medtronic(U.S) Latest Developments
Table 87. St. Jude Medical(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. St. Jude Medical(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 89. St. Jude Medical(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. St. Jude Medical(U.S) Main Business
Table 91. St. Jude Medical(U.S) Latest Developments
Table 92. Boston Scientific(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Boston Scientific(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 94. Boston Scientific(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Boston Scientific(U.S) Main Business
Table 96. Boston Scientific(U.S) Latest Developments
Table 97. Cyberonics(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Cyberonics(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 99. Cyberonics(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Cyberonics(U.S) Main Business
Table 101. Cyberonics(U.S) Latest Developments
Table 102. Cochlear(Australia) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Cochlear(Australia) Neuro Stimulation Devices Product Portfolios and Specifications
Table 104. Cochlear(Australia) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Cochlear(Australia) Main Business
Table 106. Cochlear(Australia) Latest Developments
Table 107. NDI Medical(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. NDI Medical(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 109. NDI Medical(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. NDI Medical(U.S) Main Business
Table 111. NDI Medical(U.S) Latest Developments
Table 112. NeuroPace(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. NeuroPace(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 114. NeuroPace(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. NeuroPace(U.S) Main Business
Table 116. NeuroPace(U.S) Latest Developments
Table 117. ElectroCore Medical(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. ElectroCore Medical(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 119. ElectroCore Medical(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. ElectroCore Medical(U.S) Main Business
Table 121. ElectroCore Medical(U.S) Latest Developments
Table 122. MED-EL(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. MED-EL(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 124. MED-EL(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. MED-EL(U.S) Main Business
Table 126. MED-EL(U.S) Latest Developments
Table 127. Neuronetics(U.S) Basic Information, Neuro Stimulation Devices Manufacturing Base, Sales Area and Its Competitors
Table 128. Neuronetics(U.S) Neuro Stimulation Devices Product Portfolios and Specifications
Table 129. Neuronetics(U.S) Neuro Stimulation Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Neuronetics(U.S) Main Business
Table 131. Neuronetics(U.S) Latest Developments
List of


Figure 1. Picture of Neuro Stimulation Devices
Figure 2. Neuro Stimulation Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuro Stimulation Devices Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Neuro Stimulation Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Neuro Stimulation Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of DBS(Deep-Brain Stimulation)
Figure 10. Product Picture of VNS(Vagus Nerve Stimulation)
Figure 11. Product Picture of RNS(Responsive Neuro Stimulation)
Figure 12. Product Picture of TMS(Transcranial Magnetic Stimulation)
Figure 13. Product Picture of SCS(Spinal Cord Stimulation)
Figure 14. Product Picture of PNS(Peripheral Nerve Stimulation)
Figure 15. Global Neuro Stimulation Devices Sales Market Share by Type in 2023
Figure 16. Global Neuro Stimulation Devices Revenue Market Share by Type (2019-2024)
Figure 17. Neuro Stimulation Devices Consumed in Pain Management
Figure 18. Global Neuro Stimulation Devices Market: Pain Management (2019-2024) & (Units)
Figure 19. Neuro Stimulation Devices Consumed in Parkinson’S Disease
Figure 20. Global Neuro Stimulation Devices Market: Parkinson’S Disease (2019-2024) & (Units)
Figure 21. Neuro Stimulation Devices Consumed in Urinary and Fecal Incontinence
Figure 22. Global Neuro Stimulation Devices Market: Urinary and Fecal Incontinence (2019-2024) & (Units)
Figure 23. Neuro Stimulation Devices Consumed in Epilepsy
Figure 24. Global Neuro Stimulation Devices Market: Epilepsy (2019-2024) & (Units)
Figure 25. Neuro Stimulation Devices Consumed in Hearing Loss
Figure 26. Global Neuro Stimulation Devices Market: Hearing Loss (2019-2024) & (Units)
Figure 27. Neuro Stimulation Devices Consumed in Gastroparesis
Figure 28. Global Neuro Stimulation Devices Market: Gastroparesis (2019-2024) & (Units)
Figure 29. Neuro Stimulation Devices Consumed in Depression
Figure 30. Global Neuro Stimulation Devices Market: Depression (2019-2024) & (Units)
Figure 31. Neuro Stimulation Devices Consumed in Others
Figure 32. Global Neuro Stimulation Devices Market: Others (2019-2024) & (Units)
Figure 33. Global Neuro Stimulation Devices Sales Market Share by Application (2023)
Figure 34. Global Neuro Stimulation Devices Revenue Market Share by Application in 2023
Figure 35. Neuro Stimulation Devices Sales Market by Company in 2023 (Units)
Figure 36. Global Neuro Stimulation Devices Sales Market Share by Company in 2023
Figure 37. Neuro Stimulation Devices Revenue Market by Company in 2023 ($ Million)
Figure 38. Global Neuro Stimulation Devices Revenue Market Share by Company in 2023
Figure 39. Global Neuro Stimulation Devices Sales Market Share by Geographic Region (2019-2024)
Figure 40. Global Neuro Stimulation Devices Revenue Market Share by Geographic Region in 2023
Figure 41. Americas Neuro Stimulation Devices Sales 2019-2024 (Units)
Figure 42. Americas Neuro Stimulation Devices Revenue 2019-2024 ($ Millions)
Figure 43. APAC Neuro Stimulation Devices Sales 2019-2024 (Units)
Figure 44. APAC Neuro Stimulation Devices Revenue 2019-2024 ($ Millions)
Figure 45. Europe Neuro Stimulation Devices Sales 2019-2024 (Units)
Figure 46. Europe Neuro Stimulation Devices Revenue 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Neuro Stimulation Devices Sales 2019-2024 (Units)
Figure 48. Middle East & Africa Neuro Stimulation Devices Revenue 2019-2024 ($ Millions)
Figure 49. Americas Neuro Stimulation Devices Sales Market Share by Country in 2023
Figure 50. Americas Neuro Stimulation Devices Revenue Market Share by Country in 2023
Figure 51. Americas Neuro Stimulation Devices Sales Market Share by Type (2019-2024)
Figure 52. Americas Neuro Stimulation Devices Sales Market Share by Application (2019-2024)
Figure 53. United States Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 54. Canada Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 55. Mexico Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 56. Brazil Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. APAC Neuro Stimulation Devices Sales Market Share by Region in 2023
Figure 58. APAC Neuro Stimulation Devices Revenue Market Share by Regions in 2023
Figure 59. APAC Neuro Stimulation Devices Sales Market Share by Type (2019-2024)
Figure 60. APAC Neuro Stimulation Devices Sales Market Share by Application (2019-2024)
Figure 61. China Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. Japan Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 63. South Korea Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 64. Southeast Asia Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 65. India Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. Australia Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. China Taiwan Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Europe Neuro Stimulation Devices Sales Market Share by Country in 2023
Figure 69. Europe Neuro Stimulation Devices Revenue Market Share by Country in 2023
Figure 70. Europe Neuro Stimulation Devices Sales Market Share by Type (2019-2024)
Figure 71. Europe Neuro Stimulation Devices Sales Market Share by Application (2019-2024)
Figure 72. Germany Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 73. France Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 74. UK Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 75. Italy Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 76. Russia Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 77. Middle East & Africa Neuro Stimulation Devices Sales Market Share by Country in 2023
Figure 78. Middle East & Africa Neuro Stimulation Devices Revenue Market Share by Country in 2023
Figure 79. Middle East & Africa Neuro Stimulation Devices Sales Market Share by Type (2019-2024)
Figure 80. Middle East & Africa Neuro Stimulation Devices Sales Market Share by Application (2019-2024)
Figure 81. Egypt Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 82. South Africa Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 83. Israel Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 84. Turkey Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 85. GCC Country Neuro Stimulation Devices Revenue Growth 2019-2024 ($ Millions)
Figure 86. Manufacturing Cost Structure Analysis of Neuro Stimulation Devices in 2023
Figure 87. Manufacturing Process Analysis of Neuro Stimulation Devices
Figure 88. Industry Chain Structure of Neuro Stimulation Devices
Figure 89. Channels of Distribution
Figure 90. Global Neuro Stimulation Devices Sales Market Forecast by Region (2025-2030)
Figure 91. Global Neuro Stimulation Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 92. Global Neuro Stimulation Devices Sales Market Share Forecast by Type (2025-2030)
Figure 93. Global Neuro Stimulation Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 94. Global Neuro Stimulation Devices Sales Market Share Forecast by Application (2025-2030)
Figure 95. Global Neuro Stimulation Devices Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Neuro Stimulation Devices Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.